Page last updated: 2024-09-03

sulbactam and Staphylococcal Pneumonia

sulbactam has been researched along with Staphylococcal Pneumonia in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahern, JW; Aloi, JJ; Bednarik, JL; Crookes, BA; McMillian, WD	1
Dudzevicius, V; Sakalauskas, R; Vitkauskiene, A	1
Perederko, LV; Polikarpova, SV; Postnikov, SS; Semykin, SIu	1
Hara, K; Higashiyama, Y; Koga, H; Kohno, S; Maesaki, S; Matsuda, H; Mitsutake, K; Miyazaki, Y; Yamada, H; Yoshitomi, Y	1

Trials

1 trial(s) available for sulbactam and Staphylococcal Pneumonia

Article	Year
[Efficacy and safety of cefoperazone/sulbactam in the treatment of children with mucoviscidosis during exacerbation of the bronchopulmonary process]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2003, Volume: 48, Issue:12 Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Cefoperazone; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Treatment Outcome	2003

Article

Year

[Efficacy and safety of cefoperazone/sulbactam in the treatment of children with mucoviscidosis during exacerbation of the bronchopulmonary process].

Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2003, Volume: 48, Issue:12

Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Cefoperazone; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Treatment Outcome

2003

Other Studies

3 other study(ies) available for sulbactam and Staphylococcal Pneumonia

Article	Year
Utility of ampicillin-sulbactam for empiric treatment of ventilator-associated pneumonia in a trauma population. The Journal of trauma, 2010, Volume: 69, Issue:4 Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Multiple, Bacterial; Female; Guideline Adherence; Haemophilus Infections; Haemophilus influenzae; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcus aureus; Sulbactam; Wounds and Injuries	2010
[The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests]. Medicina (Kaunas, Lithuania), 2003, Volume: 39, Issue:3 Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bronchoalveolar Lavage Fluid; Ceftazidime; Cefuroxime; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fusidic Acid; Gentamicins; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Staphylococcus aureus; Sulbactam; Vancomycin Resistance	2003
Fatal pneumonia caused by Corynebacterium group JK after treatment of Staphylococcus aureus pneumonia. Internal medicine (Tokyo, Japan), 1992, Volume: 31, Issue:7 Topics: Aged; Cefoperazone; Corynebacterium; Corynebacterium Infections; Disease Susceptibility; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Immunocompromised Host; Kidney Failure, Chronic; Male; Minocycline; Opportunistic Infections; Pneumonia; Pneumonia, Staphylococcal; Sulbactam	1992